Home   What's On   News   Article

New theatre GlassBox Theatre in Medway to stage Olivier Award-winning show, Rotterdam

A fledgling theatre which only opened this year is set to welcome its first Olivier-award winning production next month.

GlassBox Theatre opened at MidKent College in Medway Road, Gillingham, in January, aiming to create a comercial venture from the college's professional theatre space.

After starting out with a range of one night plays and short runs, the theatre will now stage Rotterdam, a play which has had a successful run in New York, from Thursday, May 9 to Saturday, May 11.

Rotterdam the play is coming to Glass Box Theatre, Medway
Rotterdam the play is coming to Glass Box Theatre, Medway

Donnacadh O’Briain’s acclaimed production, which is on a national tour,is a bittersweet comedy about gender, sexuality and being a long way from home.

Written by acclaimed playwright Jon Brittain, it's New Year in Rotterdam, and Alice has finally plucked up the courage to email her parents and tell them she's gay.

But before she can hit send, her girlfriend Fiona reveals that he has always identified as male and now wants to start living as a man named Adrian.

Now, as Adrian confronts the reality of his transition, Alice faces a question she never thought she'd ask... does this mean she's straight?

Director Donnacadh O’Briain said: "It’s a privilege to be able to share this funny, moving and beautiful story with audiences around the whole country."

While writing this show, Brittain researched and consulted widely including talking to trans people and their partners.

GlassBox Theatre is a new professional theatre and event venue, with a 332-seat auditorium,

To find out more and book tickets go to ticketsource.co.uk/midkent, call 01634 383 388 or email box.office@midkent.ac.uk or

* Look out for our feature on GlassBox Theatre in the KM Group's What's On next month.

Read more: All the latest stage and theatre news across Kent.

Close This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.Learn More